These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 26102369)

  • 1. Click Chemistry in Lead Optimization of Boronic Acids as β-Lactamase Inhibitors.
    Caselli E; Romagnoli C; Vahabi R; Taracila MA; Bonomo RA; Prati F
    J Med Chem; 2015 Jul; 58(14):5445-58. PubMed ID: 26102369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Boronic Acid Transition State Inhibitors Active against KPC and Other Class A β-Lactamases: Structure-Activity Relationships as a Guide to Inhibitor Design.
    Rojas LJ; Taracila MA; Papp-Wallace KM; Bethel CR; Caselli E; Romagnoli C; Winkler ML; Spellberg B; Prati F; Bonomo RA
    Antimicrob Agents Chemother; 2016 Jan; 60(3):1751-9. PubMed ID: 26729496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. α-Triazolylboronic Acids: A Promising Scaffold for Effective Inhibitors of KPCs.
    Introvigne ML; Taracila MA; Prati F; Caselli E; Bonomo RA
    ChemMedChem; 2020 Jul; 15(14):1283-1288. PubMed ID: 32459878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-based approach for identification of novel phenylboronic acids as serine-β-lactamase inhibitors.
    Sgrignani J; De Luca F; Torosyan H; Docquier JD; Duan D; Novati B; Prati F; Colombo G; Grazioso G
    J Comput Aided Mol Des; 2016 Oct; 30(10):851-861. PubMed ID: 27632226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-Based Analysis of Boronic Acids as Inhibitors of Acinetobacter-Derived Cephalosporinase-7, a Unique Class C β-Lactamase.
    Bouza AA; Swanson HC; Smolen KA; VanDine AL; Taracila MA; Romagnoli C; Caselli E; Prati F; Bonomo RA; Powers RA; Wallar BJ
    ACS Infect Dis; 2018 Mar; 4(3):325-336. PubMed ID: 29144724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1,2,3-Triazolylmethaneboronate: A Structure Activity Relationship Study of a Class of β-Lactamase Inhibitors against
    Caselli E; Fini F; Introvigne ML; Stucchi M; Taracila MA; Fish ER; Smolen KA; Rather PN; Powers RA; Wallar BJ; Bonomo RA; Prati F
    ACS Infect Dis; 2020 Jul; 6(7):1965-1975. PubMed ID: 32502340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical and structural analysis of inhibitors targeting the ADC-7 cephalosporinase of Acinetobacter baumannii.
    Powers RA; Swanson HC; Taracila MA; Florek NW; Romagnoli C; Caselli E; Prati F; Bonomo RA; Wallar BJ
    Biochemistry; 2014 Dec; 53(48):7670-9. PubMed ID: 25380506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of novel boronic acid transition state inhibitors to probe substrate affinity in SHV-type extended-spectrum beta-lactamases.
    Thomson JM; Prati F; Bethel CR; Bonomo RA
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1577-9. PubMed ID: 17220410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of "bora-penicilloates" with serine β-lactamases and DD-peptidases.
    Dzhekieva L; Adediran SA; Pratt RF
    Biochemistry; 2014 Oct; 53(41):6530-8. PubMed ID: 25302576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal Structures of KPC-2 and SHV-1 β-Lactamases in Complex with the Boronic Acid Transition State Analog S02030.
    Nguyen NQ; Krishnan NP; Rojas LJ; Prati F; Caselli E; Romagnoli C; Bonomo RA; van den Akker F
    Antimicrob Agents Chemother; 2016 Jan; 60(3):1760-6. PubMed ID: 26729491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serendipitous discovery of aryl boronic acids as β-lactamase inhibitors.
    Yang SW; Pan J; Root Y; Scapin G; Xiao L; Su J
    Bioorg Med Chem Lett; 2020 Jan; 30(2):126795. PubMed ID: 31759850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the inhibition of AmpC and other β-lactamases by cyclic boronates.
    Cahill ST; Tyrrell JM; Navratilova IH; Calvopiña K; Robinson SW; Lohans CT; McDonough MA; Cain R; Fishwick CWG; Avison MB; Walsh TR; Schofield CJ; Brem J
    Biochim Biophys Acta Gen Subj; 2019 Apr; 1863(4):742-748. PubMed ID: 30738906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Boronic Acid Transition State Inhibitors as Potent Inactivators of KPC and CTX-M β-Lactamases: Biochemical and Structural Analyses.
    Alsenani TA; Rodríguez MM; Ghiglione B; Taracila MA; Mojica MF; Rojas LJ; Hujer AM; Gutkind G; Bethel CR; Rather PN; Introvigne ML; Prati F; Caselli E; Power P; van den Akker F; Bonomo RA
    Antimicrob Agents Chemother; 2023 Jan; 67(1):e0093022. PubMed ID: 36602311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The complexed structure and antimicrobial activity of a non-beta-lactam inhibitor of AmpC beta-lactamase.
    Powers RA; Blázquez J; Weston GS; Morosini MI; Baquero F; Shoichet BK
    Protein Sci; 1999 Nov; 8(11):2330-7. PubMed ID: 10595535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Acinetobacter-Derived Cephalosporinase: Exploring the Carboxylate Recognition Site Using Novel β-Lactamase Inhibitors.
    Caselli E; Romagnoli C; Powers RA; Taracila MA; Bouza AA; Swanson HC; Smolen KA; Fini F; Wallar BJ; Bonomo RA; Prati F
    ACS Infect Dis; 2018 Mar; 4(3):337-348. PubMed ID: 29144725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the potential of boronic acids as inhibitors of OXA-24/40 β-lactamase.
    Werner JP; Mitchell JM; Taracila MA; Bonomo RA; Powers RA
    Protein Sci; 2017 Mar; 26(3):515-526. PubMed ID: 27997706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Boronic Acids as Prospective Inhibitors of Metallo-β-Lactamases: Efficient Chemical Reaction in the Enzymatic Active Site Revealed by Molecular Modeling.
    Krivitskaya AV; Khrenova MG
    Molecules; 2021 Apr; 26(7):. PubMed ID: 33918209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-based design guides the improved efficacy of deacylation transition state analogue inhibitors of TEM-1 beta-Lactamase(,).
    Ness S; Martin R; Kindler AM; Paetzel M; Gold M; Jensen SE; Jones JB; Strynadka NC
    Biochemistry; 2000 May; 39(18):5312-21. PubMed ID: 10820001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Boronic acid inhibitors of the class A β-lactamase KPC-2.
    Zhou J; Stapleton P; Haider S; Healy J
    Bioorg Med Chem; 2018 Jul; 26(11):2921-2927. PubMed ID: 29784271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based optimization of cephalothin-analogue boronic acids as beta-lactamase inhibitors.
    Morandi S; Morandi F; Caselli E; Shoichet BK; Prati F
    Bioorg Med Chem; 2008 Feb; 16(3):1195-205. PubMed ID: 17997318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.